Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | MITF | O75030 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | GFER | P55789 | 1/20 | 0.46 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.46 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.46 |
| ▸ | MDM4 | O15151 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30345552 | 1.00 | PTGS1 (0.56) | PTGS1KDM4ETSHRMEN1KMT2A | |
| SCHEMBL15849013 | 0.98 | PTGS1 (0.55) | PTGS1KDM4ETSHRMEN1KMT2A | |
| SCHEMBL123764 | 0.96 | PTGS1 (0.58) | PTGS1KDM4ETSHRMEN1KMT2A | |
| SCHEMBL30358257 | 0.94 | PTGS1 (0.66) | PTGS1KDM4ETSHRMEN1KMT2A | |
| SCHEMBL765113 | 0.94 | PTGS1 (0.66) | PTGS1KDM4ETSHRMEN1KMT2A | |
| SCHEMBL8636829 | 0.92 | PTGS1 (0.54) | PTGS1KDM4ETSHRMEN1KMT2A | |
| SCHEMBL26378345 | 0.90 | SMN1; SMN2 (0.59) | PTGS1KDM4ETSHRHDAC4HDAC8 | |
| SCHEMBL13183668 | 0.90 | ALDH1A1 (0.59) | PTGS1KDM4ETSHRMEN1KMT2A | |
| SCHEMBL24074781 | 0.88 | PTGS1 (0.47) | PTGS1KDM4ETSHRMEN1KMT2A | |
| SCHEMBL19317577 | 0.88 | PTGS1 (0.47) | PTGS1KDM4ETSHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113493870-B | Composite flocculant for ion type rare earth enrichment and enrichment method | 福建省长汀金龙稀土有限公司 | 2023-04-07 | — | — | CN | claimed |
| CN-113493870-A | Composite flocculant for ion type rare earth enrichment and enrichment method | 厦门钨业股份有限公司 | 2021-10-12 | — | — | CN | claimed |
| CN-113493870-B | Composite flocculant for ion type rare earth enrichment and enrichment method | 福建省长汀金龙稀土有限公司 | 2023-04-07 | — | — | CN | disclosed |
| CN-113493870-A | Composite flocculant for ion type rare earth enrichment and enrichment method | 厦门钨业股份有限公司 | 2021-10-12 | — | — | CN | disclosed |
| WO-2020135687-A1 | BORON-CONTAINING COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 江苏三月光电科技有限公司 | 2020-07-02 | — | — | WO | disclosed |
| US-8420686-B2 | Linked diimidazole antivirals | ENANTA PHARMACEUTICALS, INC. (US) | 2013-04-16 | — | — | US | disclosed |
| US-20100226882-A1 | LINKED DIIMIDAZOLE ANTIVIRALS | ENANTA PHARMACEUTICALS, INC. | 2010-09-09 | — | — | US | disclosed |
| US-4424382-A | Superacid catalyzed preparation of resorcinol from meta-isopropylepheol | PCUK PRODUITS CHIMIQUES UGINE KUHLMANN (FR) | 1984-01-03 | — | — | US | disclosed |
| US-4423254-A | Superacid catalyzed preparation of resorcinol from meta-isopropylphenol | PCUK PRODUITS CHIMIQUES UGINE KUHLMANN (FR) | 1983-12-27 | — | — | US | disclosed |
| US-4339614-A | Superacid catalyzed preparation of resorcinol from meta-isopropylphenol | PCUK PRODUITS CHIMIQUES UGINE KUHLMANN (FR) | 1982-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100226882-A1 | LINKED DIIMIDAZOLE ANTIVIRALS | EIF2AK2, ZC3HAV1, MAVS | PTGS1 1416/4885KDM4E 897/4885TSHR 4694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.